BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

606 related articles for article (PubMed ID: 32816558)

  • 41. Real-Life Experience of Monoclonal Antibody Treatments in Chronic Rhinosinusitis with Nasal Polyposis.
    Meier EC; Schmid-Grendelmeier P; Steiner UC; Soyka MB
    Int Arch Allergy Immunol; 2021; 182(8):736-743. PubMed ID: 33756474
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Efficacy of omalizumab in eosinophilic chronic rhinosinusitis patients with asthma.
    Tajiri T; Matsumoto H; Hiraumi H; Ikeda H; Morita K; Izuhara K; Ono J; Ohta S; Ito I; Oguma T; Nakaji H; Inoue H; Iwata T; Nagasaki T; Kanemitsu Y; Ito J; Niimi A; Mishima M
    Ann Allergy Asthma Immunol; 2013 May; 110(5):387-8. PubMed ID: 23622013
    [No Abstract]   [Full Text] [Related]  

  • 43. Real-life rapidity of benralizumab effects in patients with severe allergic eosinophilic asthma: Assessment of blood eosinophils, symptom control, lung function and oral corticosteroid intake after the first drug dose.
    Pelaia C; Busceti MT; Vatrella A; Rago GF; Crimi C; Terracciano R; Pelaia G
    Pulm Pharmacol Ther; 2019 Oct; 58():101830. PubMed ID: 31344472
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Radiological Versus Clinical 1-Year Outcomes of Dupilumab in Refractory CRSwNP: A Real-Life Study.
    Giombi F; Pace GM; Nappi E; Giunta G; Muci G; Pirola F; Ferreli F; Heffler E; Paoletti G; Giannitto C; Mercante G; Francone M; Spriano G; Canonica GW; Malvezzi L
    Laryngoscope; 2024 Jun; 134(6):2626-2633. PubMed ID: 38126613
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Omalizumab treats chronic rhinosinusitis with nasal polyps and asthma together-a real life study.
    Bidder T; Sahota J; Rennie C; Lund VJ; Robinson DS; Kariyawasam HH
    Rhinology; 2018 Mar; 56(1):42-45. PubMed ID: 29288573
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Evaluation of the clinical features and laboratory data of patients with severe asthma classified as super-responder or non super-responder to omalizumab treatment: a single-center real-life study.
    Cakmak ME; Öztop N; Yeğit OO; Özdedeoğlu Ö
    J Asthma; 2023 Oct; 60(10):1862-1868. PubMed ID: 36971065
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cycling therapy with benralizumab and dupilumab for severe eosinophilic asthma with eosinophilic chronic rhinosinusitis and eosinophilic otitis media.
    Hamada S; Ogino E; Yasuba H
    Allergol Int; 2021 Jul; 70(3):389-391. PubMed ID: 33685801
    [No Abstract]   [Full Text] [Related]  

  • 48. SNOT-22-based clusters in chronic rhinosinusitis without nasal polyposis exhibit distinct endotypic and prognostic differences.
    Lal D; Hopkins C; Divekar RD
    Int Forum Allergy Rhinol; 2018 Jul; 8(7):797-805. PubMed ID: 29437297
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Doxycycline may be more clinically effective in type 2 chronic rhinosinusitis nasal polyp comorbid with asthma.
    Paçacı Çetin G; Arslan B; Yılmaz İ
    J Asthma; 2024 Jan; 61(1):20-26. PubMed ID: 37437223
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Analysis of comorbidities and objective parameters in refractory chronic rhinosinusitis.
    Batra PS; Tong L; Citardi MJ
    Laryngoscope; 2013 Dec; 123 Suppl 7():S1-11. PubMed ID: 24122826
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of Omalizumab Treatment in Patients With Recalcitrant Nasal Polyposis and Mild Asthma: A Multicenter Retrospective Study.
    Armengot-Carceller M; Gómez-Gómez MJ; García-Navalón C; Doménech-Campos E; Muñoz-Fernández N; Miguel AG; Marco-Algarra J; Palop-Cervera M; Piñero AG
    Am J Rhinol Allergy; 2021 Jul; 35(4):516-524. PubMed ID: 33153272
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Efficacy of benralizumab for patients with severe eosinophilic asthma: a retrospective, real-life study.
    Numata T; Miyagawa H; Nishioka S; Okuda K; Utsumi H; Hashimoto M; Minagawa S; Ishikawa T; Hara H; Araya J; Kuwano K
    BMC Pulm Med; 2020 Aug; 20(1):207. PubMed ID: 32746787
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Omalizumab improves sinonasal outcomes in patients with chronic rhinosinusitis with nasal polyps regardless of allergic status.
    Gevaert P; Mullol J; Saenz R; Ko J; Steinke JW; Millette LA; Meltzer EO
    Ann Allergy Asthma Immunol; 2024 Mar; 132(3):355-362.e1. PubMed ID: 37951571
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Omalizumab is effective in allergic and nonallergic patients with nasal polyps and asthma.
    Gevaert P; Calus L; Van Zele T; Blomme K; De Ruyck N; Bauters W; Hellings P; Brusselle G; De Bacquer D; van Cauwenberge P; Bachert C
    J Allergy Clin Immunol; 2013 Jan; 131(1):110-6.e1. PubMed ID: 23021878
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Age related non-type 2 inflammation and its association with treatment outcome in patients with chronic rhinosinusitis with nasal polyp in Korea.
    Kim JW; Won TB; Woo H; Yang SK; Phannikul C; Ko SA; Kim H; Rhee CS; Cho SW
    Sci Rep; 2022 Jan; 12(1):1671. PubMed ID: 35102253
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Lower Airway Inflammation in Eosinophilic Chronic Rhinosinusitis as Determined by Exhaled Nitric Oxide.
    Kambara R; Minami T; Akazawa H; Tsuji F; Sasaki T; Inohara H; Horii A
    Int Arch Allergy Immunol; 2017; 173(4):225-232. PubMed ID: 28848094
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Efficacy of mepolizumab for patients with severe asthma and eosinophilic chronic rhinosinusitis.
    Numata T; Nakayama K; Utsumi H; Kobayashi K; Yanagisawa H; Hashimoto M; Minagawa S; Ishikawa T; Hara H; Araya J; Kuwano K
    BMC Pulm Med; 2019 Oct; 19(1):176. PubMed ID: 31606052
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Antibiotics in eosinophilic chronic rhinosinusitis: Rethinking maximal antimicrobial medical therapy.
    Günel C; Bleier BS; Meteoglu I
    Laryngoscope; 2017 Apr; 127(4):794-796. PubMed ID: 27888519
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Efficacy and safety of dupilumab in patients with uncontrolled severe chronic rhinosinusitis with nasal polyps and a clinical diagnosis of NSAID-ERD: Results from two randomized placebo-controlled phase 3 trials.
    Mullol J; Laidlaw TM; Bachert C; Mannent LP; Canonica GW; Han JK; Maspero JF; Picado C; Daizadeh N; Ortiz B; Li Y; Ruddy M; Laws E; Amin N
    Allergy; 2022 Apr; 77(4):1231-1244. PubMed ID: 34459002
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Predictors of efficacy for combination oral and topical corticosteroids to treat patients with chronic rhinosinusitis with nasal polyps.
    Epperson MV; Phillips KM; Caradonna DS; Gray ST; Sedaghat AR
    Int Forum Allergy Rhinol; 2019 Dec; 9(12):1436-1442. PubMed ID: 31609091
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.